EP Patent

EP2981258B8 — Pharmaceutical formulations for subcutaneous administration of furosemide

Assigned to ScPharmaceuticals Inc · Expires 2020-11-11 · 6y expired

What this patent protects

Patent listed against Lasix.

Drugs covered by this patent

Lasix (furosemide) · Generic (originally Hoechst AG)

Patent Metadata

Patent number: EP2981258B8
Jurisdiction: EP
Classification: —
Expires: 2020-11-11
Drug substance claim: No
Drug product claim: No
Assignee: ScPharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.